Cargando…

Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines

Newcastle disease virus (NDV) causes a devastating poultry disease worldwide. Frequent outbreaks of NDV in chickens vaccinated with conventional live vaccines suggest a need to develop new vaccines that are genetically matched against circulating NDV strains, such as the genotype V virulent strains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Shin-Hee, Chen, Zongyan, Yoshida, Asuka, Paldurai, Anandan, Xiao, Sa, Samal, Siba K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365116/ https://www.ncbi.nlm.nih.gov/pubmed/28339499 http://dx.doi.org/10.1371/journal.pone.0173965

Ejemplares similares

Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine
por: Manoharan, Vinoth K., et al.
Publicado: (2018)

Newcastle Disease Virus Fusion Protein Is the Major Contributor to Protective Immunity of Genotype-Matched Vaccine
por: Kim, Shin-Hee, et al.
Publicado: (2013)

Sequence analysis of fusion protein gene of Newcastle disease virus isolated from outbreaks in Egypt during 2006
por: Mohamed, Mahmoud HA, et al.
Publicado: (2011)

Complete Genome Sequence of a Highly Virulent Newcastle Disease Virus Currently Circulating in Mexico
por: Xiao, Sa, et al.
Publicado: (2013)

Role of fusion protein cleavage site in the virulence of Newcastle disease virus
por: Panda, Aruna, et al.
Publicado: (2004)

Effects of Naturally Occurring Six- and Twelve-Nucleotide Inserts on Newcastle Disease Virus Replication and Pathogenesis
por: Paldurai, Anandan, et al.
Publicado: (2014)

Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens
por: Kim, Shin-Hee, et al.
Publicado: (2014)

Expression of Concern: Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines
Publicado: (2020)

Novel avian paramyxovirus-based vaccine vectors expressing the Ebola virus glycoprotein elicit mucosal and humoral immune responses in guinea pigs
por: Yoshida, Asuka, et al.
Publicado: (2019)

A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV
por: Shirvani, Edris, et al.
Publicado: (2018)

Author Correction: A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV
por: Shirvani, Edris, et al.
Publicado: (2020)

Generation by Reverse Genetics of an Effective, Stable, Live-Attenuated Newcastle Disease Virus Vaccine Based on a Currently Circulating, Highly Virulent Indonesian Strain
por: Xiao, Sa, et al.
Publicado: (2012)

Correction: Generation by Reverse Genetics of an Effective, Stable, Live-Attenuated Newcastle Disease Virus Vaccine Based on a Currently Circulating, Highly Virulent Indonesian Strain
por: Xiao, Sa, et al.
Publicado: (2022)

Complete Genome Sequence of an Avian Paramyxovirus Type 4 from North America Reveals a Shorter Genome and New Genotype
por: Parthiban, Manoharan, et al.
Publicado: (2013)

Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines
por: Kim, Shin-Hee, et al.
Publicado: (2019)

Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines
por: Kim, Shin-Hee, et al.
Publicado: (2016)

Mutations in the Fusion Protein Cleavage Site of Avian Paramyxovirus Serotype 4 Confer Increased Replication and Syncytium Formation In Vitro but Not Increased Replication and Pathogenicity in Chickens and Ducks
por: Kim, Shin-Hee, et al.
Publicado: (2013)

Complete Genome Sequence of Avian Paramyxovirus (APMV) Serotype 5 Completes the Analysis of Nine APMV Serotypes and Reveals the Longest APMV Genome
por: Samuel, Arthur S., et al.
Publicado: (2010)

Development of a recombinant Newcastle disease virus-vectored vaccine for infectious bronchitis virus variant strains circulating in Egypt
por: Abozeid, Hassanein H., et al.
Publicado: (2019)

Contributions of HA1 and HA2 Subunits of Highly Pathogenic Avian Influenza Virus in Induction of Neutralizing Antibodies and Protection in Chickens
por: Shirvani, Edris, et al.
Publicado: (2020)

A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge
por: Shirvani, Edris, et al.
Publicado: (2020)

Author Correction: A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge
por: Shirvani, Edris, et al.
Publicado: (2020)

Evaluation of the Replication, Pathogenicity, and Immunogenicity of Avian Paramyxovirus (APMV) Serotypes 2, 3, 4, 5, 7, and 9 in Rhesus Macaques
por: Khattar, Sunil K., et al.
Publicado: (2013)

Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2
por: Shirvani, Edris, et al.
Publicado: (2020)

Retraction: Newcastle disease virus fusion protein is the major contributor to protective immunity of genotype-matched vaccine
Publicado: (2020)

Avian Paramyxovirus Type-3 as a Vaccine Vector: Identification of a Genome Location for High Level Expression of a Foreign Gene
por: Yoshida, Asuka, et al.
Publicado: (2017)

Comprehensive analysis of amino acid sequence diversity at the F protein cleavage site of Newcastle disease virus in fusogenic activity
por: Wang, Yanhong, et al.
Publicado: (2017)

Fusion Protein Cleavage Site Containing Three Basic Amino Acids Attenuates Newcastle Disease Virus in Chicken Embryos: Use as an in ovo Vaccine
por: Feng, Helong, et al.
Publicado: (2022)

Modified Newcastle Disease virus as an improved vaccine vector against Simian Immunodeficiency virus
por: Manoharan, Vinoth K., et al.
Publicado: (2018)

Protective efficacy of the Newcastle disease virus genotype VII–matched vaccine in commercial layers
por: Sultan, Hesham A., et al.
Publicado: (2020)

Efficacy of the Newcastle Disease Virus Genotype VII.1.1-Matched Vaccines in Commercial Broilers
por: Sultan, Hesham A., et al.
Publicado: (2021)

Co-expression of the Hemagglutinin and Neuraminidase by Heterologous Newcastle Disease Virus Vectors Protected Chickens against H5 Clade 2.3.4.4 HPAI Viruses
por: Cho, Yeonwoo, et al.
Publicado: (2018)

Two mutations in the HR2 region of Newcastle disease virus fusion protein with a cleavage motif “RRQRRL” are critical for fusogenic activity
por: Wang, Yanhong, et al.
Publicado: (2017)

Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2013)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2014)

Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans
por: DiNapoli, Joshua M., et al.
Publicado: (2009)

Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1
por: Khattar, Sunil K., et al.
Publicado: (2010)

Genotype-matched Newcastle disease virus vaccine confers improved protection against genotype XII challenge: The importance of cytoplasmic tails in viral replication and vaccine design
por: Izquierdo-Lara, Ray, et al.
Publicado: (2019)

Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response
por: DiNapoli, Joshua M., et al.
Publicado: (2010)

Complete Genome Sequences of Two Newcastle Disease Virus Strains of Genotype VIII
por: Cao, Yongzhong, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8mguac1n2528pqdrhpnkmcof2k